Skip to content

Methylphenidate effect on fine motor skills of children with attention deficit/hyperactivity disorder

Evaluation of methylphenidate’s effect on motor skills disorder in children with ADHD and developmental coordination disorder referred to Shafa hospital, Rasht 1390

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201107071483N2
Enrollment
32
Registered
2011-07-13
Start date
2011-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

developmental coordination disorder. Specific developmental disorder of motor function

Interventions

Intervention 1: methylphenidate therapy for one week. Intervention 2: placebo for one week.
Treatment - Drugs
Placebo
methylphenidate therapy for one week
placebo for one week

Sponsors

Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 11 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 6-11 years old, IQ score more than 70 on Raven's intelligence test, No associated psychiatric disorders (pervasive developmental disorders, anxiety, conduct, mood disorders and schizophrenia), recent disease of ADHD-C or drug therapy less than 3 months prior to the study, No medical diseases (neurologic problems, seizures, cerebral palsy, sensory deficits including vision and hearing) Exclusion criteria: occurrence of side effects, poor compliance / irregular drug consumption

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
BOT 2 score. Timepoint: before intervention, the end of first and second week. Method of measurement: BOT 2 test.

Secondary

MeasureTime frame
Measurement of effective dosage of methylphenidate. Timepoint: before intervention and the end of 1, 2, 3 and 4 week. Method of measurement: ADHD symptoms checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Robabeh Soleimani Talemi

Guilan University of Medical Sciences

mmjalali@gums.ac.ir+98 13 1666 6268

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026